Core Viewpoint - Guangdong Province is advancing the construction of a national traditional Chinese medicine (TCM) comprehensive reform demonstration zone, aiming for high-quality development in the TCM sector through the establishment of five key areas. Group 1: Medical High Ground - 14 hospitals have entered the top 100 in the national performance assessment of public TCM hospitals, with 80 specialties recognized as national advantageous specialties [1] - The total number of TCM outpatient services is projected to reach 252 million visits in 2024, accounting for 26.2% of the total outpatient visits in the province [1] Group 2: Innovation High Ground - A three-in-one innovation system comprising "key laboratories + innovation platforms + clinical transformation" has been established, with 16 TCM-related scientific achievements awarded provincial science and technology progress awards in the past three years, including 6 first prizes [1] Group 3: Talent High Ground - The province boasts 2 academicians, 4 national TCM masters, 8 renowned TCM practitioners, 188 national-level TCM talents, and over 300 provincial-level TCM practitioners, with a TCM general practitioner ratio of 0.93 per 10,000 people [1] Group 4: Industry High Ground - 22 varieties of southern medicine have been recognized as national special and superior new agricultural products, with 4 national-level and 18 provincial-level southern medicine industrial parks established. The revenue of the large-scale TCM industry is expected to reach 65.559 billion yuan in 2024 [1] Group 5: International Cooperation High Ground - The Guangdong-Hong Kong-Macao Greater Bay Area TCM inheritance and innovation development conference has been organized, facilitating high-quality exchange and cooperation, with over 50,000 bottles of 9 varieties of hospital preparations cross-border dispensed to Macau [2] - A total of 24 traditional Chinese medicine products have completed international registration and filing through the Guangdong-Macao cooperation TCM technology industrial park [2] Group 6: Management and Talent Reform - All cities and 95% of counties (districts) have established TCM management institutions, with 5 secondary and above public comprehensive hospitals transformed into TCM hospitals, optimizing the layout of TCM medical institutions [2] - A total of 4,865 senior professional titles have been approved since the implementation of the talent evaluation system, with 61 individuals obtaining provincial-level senior titles in the past three years [2] Group 7: Drug Approval and Insurance Mechanism - Guangdong has reformed the drug review and approval system, promoting the integration of TCM in the Greater Bay Area, with the establishment of an expert committee for TCM standards and the release of 7 TCM standards [3] - A total of 1,336 traditional Chinese medicine products, 1,655 TCM decoction pieces, and 136 traditional TCM diagnostic and treatment projects have been included in the medical insurance payment scope by 2025 [3]

Group 1 - In 2025, Chinese companies are shifting from cross-border operations to deeper localization and accelerating globalization in response to changing overseas policies [2] - The U.S. government has implemented policies such as the cancellation of tax exemptions for cross-border packages under $800 and reciprocal tariffs, while the EU has introduced the New Battery Law [2] - Chinese enterprises are transitioning from "single product exports" to "full-chain system output," with market strategies evolving from a focus on Europe and the U.S. to a dual-driven approach involving emerging and traditional markets [2] Group 2 - The EDGE AWARDS recognizes companies that have achieved significant breakthroughs in overseas markets despite fluctuating international conditions, highlighting their contributions to globalization [3] - ECARX has achieved large-scale production and delivery in global markets, securing over $1 billion in overseas orders and achieving profitability in Q3 [3] - Alibaba Cloud is enhancing its global infrastructure to support Chinese enterprises' overseas development, focusing on AI product internationalization and building a global cloud computing network [4] Group 3 - HLA has expanded its global strategy, opening new stores in Southeast Asia, Central Asia, and the Middle East, with overseas revenue increasing by 27.42% [4] - Kudi Coffee has expanded its international presence to 33 countries, with over 18,000 stores globally, ranking third worldwide in the coffee and tea sector [4] - United Imaging Healthcare has seen overseas revenue grow from $40 million to over $2 billion in seven years, with a compound annual growth rate of 93% [5] Group 4 - Pop Mart has experienced explosive growth in overseas revenue, which increased by 437.5% in the first half of 2025, accounting for 40.3% of total revenue [6] - Century Huatong, a leading gaming company, has achieved over $3.8 billion in global revenue from its game "Whiteout Survival" and is actively exploring AI gaming applications [7] - Tongwei Group has a global market share of approximately 30% in polysilicon, with significant growth in component sales across various regions [8] Group 5 - Yanghe Distillery has established a comprehensive international communication system focusing on high-end, platform-based, and localized strategies, covering 86 countries and regions [9] - Yiling Pharmaceutical has successfully registered 17 innovative traditional Chinese medicines in over 50 countries, promoting a multi-faceted approach to global healthcare [10] - The trend of collaborative globalization is emphasized, with companies providing reliable service networks to support Chinese enterprises in overseas markets [11] Group 6 - Amazon Global Selling has facilitated the entry of numerous Chinese sellers into international markets, signing cooperation agreements with various provincial commerce departments [12] - XTransfer offers cross-border financial and risk control services to over 800,000 enterprises, enhancing global competitiveness for small and medium-sized businesses [13] - Huawei Cloud has expanded its global presence with 34 geographic regions and 101 available zones, supporting local industry upgrades in various countries [14] Group 7 - Stripe provides programmable financial services to millions of businesses, enabling Chinese brands to establish payment channels and innovative revenue models as they expand globally [15]

（来源：河北日报） 坚持人才强院。5年累计录用313人，引进副高级及以上人才10人；职称晋升体系完善，2021年以来99人 晋升副高级及以上职称。目前医院拥有高级职称181人，博士2人，硕士199人，享受国务院政府特殊津 贴专家1人，全国名老中医2人，全国中医临床优秀人才5人，河北省名中医8人，河北省中医药国际合作 领军人才1人，"燕赵英才"10人，市级名中医12人，人才梯队结构合理，专业力量雄厚。推行"外派进修 +院内师承"双轨培育，选送184名中青年骨干赴全国知名医院深造；依托"师带徒"模式，31名师承导师 结对培养80名继承人，为核心战略实施储备中坚力量。 坚持质量建院。优化专科结构，2022年以来，获批2个国家中医优势专科（脾胃病科、心血管科），10 个省级优势专科及3个省级优势建设单位及1个河北省中医药重点研究室（内分泌科），为搭建区域内中 医优势专科集群奠定了基础。2024年，全院门诊服务量首次突破41万人次，较2022年增长63.02%；手 术量首次突破3000例，其中三四级手术完成1619例，增长154.16%。2025年1—10月，增长势头更加强 劲，全院门诊服务量较2024年同期增长19. ...

Core Insights - Zhongjing Food has officially launched its new products, concentrated ginseng liquid and ginseng tea, which contain 100mg of ginsenosides per bag, marking the first health drink with clearly defined core nutritional components [2][3] - The company is expanding into the health food sector amid pressure on its main condiment business, leveraging its strong traditional Chinese medicine background [2][3][8] Product Launch - The new ginseng products are designed to provide consumers with a reliable modern dietary solution and are currently available on online platforms, with offline channels still being developed [3] - The introductory price for both products is set at 9.9 yuan, while regular prices range from 79 yuan to 199 yuan [3] - Initial sales data shows low consumer engagement, with multiple product links on Tmall and JD indicating "0 purchases" [3] Market Trends - Over 70% of consumers aged 18-35 are willing to pay a premium for foods with specific health benefits, driving rapid growth in the health food market, which is projected to reach 1.2 trillion yuan by 2025, with a year-on-year growth of 16.8% [4] - Ginseng is a popular ingredient in this sector, and the National Health Commission has included it in the list of food-medicine homologous products [4] Challenges - The market currently offers ginseng primarily in traditional forms such as slices, powders, and capsules, which may lead to consumer skepticism regarding the new concentrated liquid and tea formats [4] - Zhongjing Food's condiment business is facing growth pressures, with sales of its flagship mushroom sauce reaching 324 million yuan in 2022, but new product launches have not replicated this success [5][6] Financial Performance - The company's revenue growth has slowed, with projected revenues of 999.4 million yuan and 1.098 billion yuan for 2023 and 2024, respectively, showing a decline in growth rate from 12.77% to 10.4% [6] - In the first three quarters of 2025, revenue decreased by 1.56% to 826 million yuan, while net profit increased by 3.18% to 154 million yuan [6] Strategic Recommendations - To overcome growth bottlenecks, Zhongjing Food should adopt a "single focus, multiple brands" strategy, maintaining its market position in mushroom sauce while expanding into health sectors with differentiated branding [7] - The company should leverage its "Chinese medicine gene" and technical expertise from its controlling shareholder to create unique products that stand out in the market [8] - Emphasizing the clear nutritional benefits and convenience of the new ginseng products through online marketing and offline experiences can help shift consumer perceptions and expand market reach [9]

人民财讯12月24日电，据北京亦庄官微消息，12月26日至27日，第二届世界中医药康养大会将在北京经 济技术开发区(北京亦庄)丰大国际大酒店举办。本届大会以"加快新时代中医药科技成果转化，推动全 球康养事业与产业高质量发展"为主题，致力于打造集学术交流、成果展示、资源对接于一体的国际高 端平台。 ...

Core Viewpoint - Cai Tong De Tang, a traditional Chinese medicine establishment in Nanjing Road, has evolved over 143 years to integrate local medicinal materials, refined herbal pieces, traditional Chinese medical diagnosis, and cultural dissemination into a comprehensive health service entity, showcasing its commitment to public health and cultural heritage [1][15]. Group 1: Historical Significance and Craftsmanship - Established in 1882, Cai Tong De Tang has become a trusted health station for many Shanghai residents, particularly the elderly, through its dedication to traditional craftsmanship and quality service [3][5]. - The establishment is known for its unique hand-cooked medicinal paste, adhering to ancient methods, and emphasizes transparency by returning the residue of precious herbs to customers for verification [3][5]. Group 2: Community Engagement and Services - Cai Tong De Tang actively engages with the community by providing regular health consultations, wellness lectures, and free health services, including blood pressure measurements, to enhance public health awareness [13]. - The establishment hosts annual free medical consultation events featuring renowned traditional Chinese medicine experts, making quality healthcare accessible to the public [13][15]. Group 3: Cultural Exchange and International Outreach - The establishment serves as a cultural bridge for international visitors to experience traditional Chinese medicine, collaborating with Shanghai University of Traditional Chinese Medicine to create immersive cultural experiences [8][10]. - Since 2019, Cai Tong De Tang has welcomed nearly a thousand international guests from various countries, allowing them to engage with Chinese medicinal practices and philosophies [12].

本报讯 记者刘会芳报道 日前，五华区大观街道富春社区联合如安堂中医馆、腾药、福林堂等单位举 办"冬至暖邻 健康同行"——如安邻里健康集市主题活动，让居民在家门口就能享受专业义诊、养生指 导等多重健康福利。 此次活动通过"社区牵头、资源整合、志愿服务"模式，加强"社商居"暖心联动，有效整合专业健康资 源，满足社区居民需求，进一步增强了社区凝聚力与邻里情。 活动现场，中医体质辨识与咨询专区备受欢迎。医师志愿者通过传统中医诊疗方法，为居民细致分析体 质状况，提供个性化养生调理建议，引导居民树立科学健康理念。针对高血压、脾胃调理等问题，志愿 者结合中医养生知识，为居民详细讲解日常注意事项与保健方法。此外，志愿者向居民普及"冬养藏"等 中医季节性养生知识，并介绍一些简便易行的居家保健方法。在古法艾灸推拿体验区，志愿者为有需要 的居民提供舒缓服务。 活动还携手高校青年志愿者，设置中医药文化展示角，通过中药香囊、养生知识展板等载体，生动展示 中医药文化魅力。眼科健康志愿服务团队为居民提供专业的视力筛查与眼健康咨询服务，耐心解答各类 用眼疑问，普及爱眼护眼知识。活动现场还设置互动环节，参与各项健康体验的居民可获得健康宣传 品 ...

Core Viewpoint - The establishment of the "De Yi Traditional Chinese Medicine Innovation and Transformation Center" marks a significant step in Shenzhen's efforts to develop a leading TCM innovation city and a strategic platform for the inheritance and innovation of TCM in the Guangdong-Hong Kong-Macao Greater Bay Area [1][2]. Group 1: Challenges and Objectives - The TCM sector faces challenges such as insufficient inheritance, lack of innovation, and ineffective transformation mechanisms [2]. - Shenzhen, despite its advantages, still lags behind cities like Beijing and Shanghai in TCM innovation and patent output [2]. - The center aims to leverage the unique policies and advantages of the He Tao Cooperation Zone to explore new paths for TCM modernization, industrialization, and internationalization [2]. Group 2: Development Framework - The center's construction is a systematic restructuring rather than mere spatial expansion, with a clear top-level design [3]. - It establishes a "one-three-five-seven" development system, focusing on creating an international TCM innovation transformation platform [3]. - The three platforms include a TCM health product drug transformation platform, an intelligent TCM equipment system platform, and a Hong Kong-Shenzhen TCM cooperation exchange platform [3]. Group 3: Core Advantages and Focus Areas - The center will focus on major chronic diseases such as cardiovascular diseases, diabetes, tumors, and respiratory diseases, utilizing the clinical foundation of Guangzhou University of Chinese Medicine Shenzhen Hospital [4]. - It aims to enhance technology research and product innovation through multi-party collaboration and complementary advantages [4]. Group 4: Systematic Support and International Collaboration - The center will establish a comprehensive support system from laboratory to market, including a professional concept verification and small-scale testing base [5]. - A technical transfer team will provide one-stop services covering intellectual property, outcome evaluation, and commercial connections [5]. - The center will promote AI technology integration and international collaboration, connecting global resources to advance TCM innovation [5]. Group 5: Collaborative Mechanisms and New Business Models - The center will promote cross-border joint research mechanisms and resource sharing among universities, research institutions, and enterprises in the Greater Bay Area [6]. - It will explore new business models combining TCM, health care, and tourism, developing cross-border health tourism products [7]. Group 6: Initial Achievements and Future Outlook - The center has already made progress in areas such as in-hospital formulation development, intelligent TCM equipment research, and patent transformation [8]. - It has signed cooperation agreements with over 20 domestic and international institutions and enterprises, establishing a diversified ecosystem for industry-university-research collaboration [8]. - The center aims to build a national-level TCM inheritance and innovation center, creating a virtuous cycle of research, transformation, industry, and promotion [8].

Core Viewpoint - Gansu Longshen Rongfa Pharmaceutical Co., Ltd. has received official certification for its health product "Huangqi Danggui Capsules" from the Macao Special Administrative Region, allowing it to enter the Macao market without prior drug import permits, marking a significant milestone in the company's expansion into the Guangdong-Hong Kong-Macao Greater Bay Area and international markets [1][2]. Group 1 - The "Huangqi Danggui Capsules" are made from traditional medicinal materials Huangqi and Danggui, combined with microcrystalline cellulose and silicon dioxide, adhering to traditional Chinese medicine principles and modern formulation techniques, and have been scientifically validated for their protective functions against radiation hazards [1]. - The "Macao Non-Drug Certification" system is a unique regulatory framework established by the Macao government for high-value functional foods and health products, providing a clear pathway for quality health products and facilitating access to markets in Portuguese-speaking countries, the EU, Latin America, and the Middle East [2]. - The recognition of "Huangqi Danggui Capsules" not only serves as an authoritative endorsement of its quality, safety, and efficacy by the Macao government but also signifies a critical step in the company's strategy to internationalize traditional Chinese medicine health products [2]. Group 2 - In recent years, the company has actively expanded its international presence through its wholly-owned subsidiary, Gansu New Silk Road Industrial Investment Co., Ltd., targeting markets in East Asia, Central Asia, Southeast Asia, and Europe, with successful product registration and export sales in Russia, Kyrgyzstan, Singapore, and Thailand [2]. - The company plans to leverage its full industry chain advantages in traditional Chinese medicine cultivation, deep processing, research, and production to enhance product quality and technological innovation, while actively researching and aligning with health product regulations in different countries and regions [3]. - The company aims to provide high-quality health solutions derived from China to global consumers, contributing to the "Healthy China" initiative and the internationalization of traditional Chinese medicine [3].

Group 1 - The annual meeting of the Ji'an Traditional Chinese Medicine (TCM) Physician Professional Committee was successfully held, with over 160 participants including officials and representatives from various pharmaceutical companies [1][3] - The meeting summarized the work of the committee for 2025 and outlined key tasks for 2026, emphasizing the importance of innovation and development in TCM practices [3][4] - Key tasks for 2026 include compiling a selection of excellent case studies, conducting professional training sessions, promoting provincial TCM platforms, and organizing academic exchanges [3][4] Group 2 - The meeting highlighted the need for continuous improvement in professional skills and service capabilities among TCM practitioners, advocating for collaboration and the integration of traditional values with modern practices [4] - Financial reports for 2025 were presented, and discussions on TCM diagnostic techniques and clinical practices were conducted, fostering deeper academic exchanges [4] - The meeting aimed to unify thoughts, build consensus, and clarify direction for the future development of TCM in Ji'an, contributing to the health and wellness of the community [4]